Business Wire

Crown Bioscience Increases APAC Capacity with New Facility in Zhongshan, China

Share

Crown Bioscience, a JSR Life Sciences company, today announces the opening of a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005098/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

CrownBio's New Zhongshan, China Facility (Photo: Business Wire)

In addition to the Company’s four facilities across the US and Europe, CrownBio’s existing APAC footprint currently includes three sites located in Beijing, Taicang, and Suzhou, as well as one in Taiwan. Once completed, this new building will add more than 2,000m2 of new vivarium space to support CrownBio’s in vivo oncology platforms, helping satisfy predicted near-term growth.

CrownBio’s world-leading products and services are used by pharmaceutical and biotech customers across APAC, North America, and Europe to accelerate and de-risk their drug discovery programs. With the significant and continued growth of CrownBio’s client base, the Zhongshan facility has been purpose built to meet expanding study needs.

The research and drug development facility features BSL-2 laboratories and will include a state-of-the-art ABSL-2 vivarium. Initial capabilities will focus on expanding cell line-derived xenograft model availability and study throughput, with an increased roster of cutting edge, translational oncology models becoming available. Full operational capacity is expected in early 2021.

“The establishment of our new Zhongshan facility demonstrates our continued commitment to our clients, to provide sustained rapid study initiation combined with robust cost-effectiveness,” said John Gu, chief operating officer at CrownBio. “Through our growth, we can more fully support our clients in their goals of more rapid and efficient cancer drug development”.

A site opening event and ribbon cutting ceremony will take place on October 30th 2020.

About Crown Bioscience Inc.

Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, inflammation, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, visit:

https://www.crownbio.com

https://www.jsrlifesciences.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Enquiries:
Jody Barbeau
Crown Bioscience Inc.
pr@crownbio.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Amit Roy Appointed to Spearhead Newly Launched Global Phosphorus Institute16.6.2021 09:00:00 CEST | Press release

The newly launched Global Phosphorus Institute (GPI) announced today the appointment of Dr. Amit Roy as Executive Director to develop and lead the Institute. His initial focus will be creating the Consortium for cutting-edge phosphorus research projects, building global coalitions, and establishing research hubs around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616005021/en/ Amit Roy - Executive Director of the GPI (Photo: AETOSWire) “We are pleased that Amit joins GPI to direct this new global initiative,” said Hicham El Habti, the President of Mohammed VI Polytechnic University, Morocco (UM6P) and President of the GPI. “His vast experience combined with his enormous breadth of knowledge, research work and experience in managing the International Fertilizer Development Center are valuable assets to GPI. I am confident that his qualifications will make him succeed in building out this Institute” Amit Roy ha

BehavioSec Granted U.S. Patents for Mobile Authentication and Social Engineering Detection16.6.2021 09:00:00 CEST | Press release

BehavioSec, the industry pioneer and technology leader for behavioral biometrics and continuous authentication, today announced the successful grant of two additional U.S. patents for its innovative method of verifying user identity and detecting fraud. Since its 2008 founding, BehavioSec has successfully been granted 24 U.S. patents, demonstrating the company’s continual commitment to the innovation and development of behavioral biometrics technology. With this new addition to their patent portfolio, BehavioSec technology can better protect digital identities and consumers on mobile devices from increasingly sophisticated, social engineering attacks – helping stop fraud before the damage is done. Today, BehavioSec already protects over 180 million people and 20 billion annual transactions across the globe. But as mobile devices continue to increase as a means of conducting financial transactions and accessing account information, consumers and institutions are often trading security a

Brains Bioceutical Corp. Completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing16.6.2021 08:00:00 CEST | Press release

Brains Bioceutical Corp. (“Brains” or the “Company”) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders. DSM Venturing, who acted as lead investor in this round, is the corporate venture arm of Royal DSM (“DSM”), a global, purpose led science-based company active in health, nutrition and sustainable living. This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. Del Morgan & Co. acted as Brains’ financial agent in respect to the capital raise. “The completion of the capital raise marks an exciting milestone for the Brains’ team. To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry,” said Brains' CEO & Chairman Rick Brar. “The growing demand for isolated CBD Active Pharmaceutical Ingredients (API’s) within the pharmaceutical and nutraceutical i

Kalray Unveils Its K200-LP Latest Acceleration Card for Data Centers16.6.2021 07:30:00 CEST | Press release

Kalray (Euronext Growth Paris: ALKAL), a leading provider in the new generation of processors specialized in Intelligent Data Processing from Cloud to Edge, today unveils its new K200-LP™ acceleration card. K200-LP™ is a new member of Kalray’s fully programmable multi-purpose acceleration card family, based on its unique MPPA® processor, and offering an unprecedented level of performance and targeting the booming NVMe based storage market as its first implementation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210615006166/en/ Kalray's K200-LP Acceleration Card (Photo: Kalray) The explosion of data, driven by demanding services and applications using AI and data analytics, is putting a lot of pressure on Cloud and Edge Data Center’s networking and storage to feed the demanding compute intensive resources. The primary needs are to reduce latency, enhance bandwidth and IOPs1 performance as well as offloading host CPUs, at b

Wipro joins World Economic Forum’s Partnership for New Work Standards initiative16.6.2021 07:03:00 CEST | Press release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has joined the World Economic Forum’s Partnership for New Work Standards initiative to establish a healthy, resilient and equitable future of work. This initiative aims to co-create new frameworks, shape forward-thinking people policies and utilize tools and technologies to collectively build human-first work standards, with people at the heart of business. Saurabh Govil, President and Chief Human Resources Officer, Wipro Limited, said, “Companies around the world today are reinventing themselves so they can offer better employee flexibility, stability and security. Wipro is committed to advancing work standards for improved job quality, employee safety, and overall employee well-being. As we join the World Economic Forum’s Partnership for New Work Standards initiative, we hope to contribute to global discussions and beha

Luminary Launches New Subscription Channel on Apple Podcasts15.6.2021 21:27:00 CEST | Press release

Luminary, a subscription podcast network, today launched a new channel on Apple Podcasts, making all Luminary Original podcasts available globally to Apple Podcasts listeners in more than 170 countries. “We’re thrilled to collaborate with Apple, the house that built podcasting, to bring our original content to millions of listeners across the world,” said Simon Sutton, Luminary CEO. “When we founded Luminary, we believed that supporting premium subscription podcast content was important to listeners and creators alike. Distributing our content on Apple Podcasts is a critical step in fulfilling our vision,” said Matt Sacks, Luminary Co-founder and Executive Chairman. The Luminary channel includes more than 30 Luminary Original podcasts including Under the Skin with Russell Brand, Snap Judgment Presents: Spooked, The C-Word with Lena Dunham, and Leon Neyfakh’s Fiasco. The Luminary channel also includes access to The Midnight Miracle, a new show from creators Talib Kweli, yasiin bey, and

Pony.ai Becomes First Company to Test Driverless Vehicles on Public Roads in Both the U.S. and China15.6.2021 21:00:00 CEST | Press release

Silicon Valley-based Pony.ai, a leading autonomous driving company, today announced that it has begun regular and daily fully driverless testing on public roads in Fremont and Milpitas, CA. Along with the recent launch of fully driverless testing in Guangzhou, China, the company has become the first to get fully driverless automated vehicles on public roads in three cities across the world's two most dynamic mobility markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210615005458/en/ The successful kick-off is authorized by the previously announced driverless permit received from the California Department of Motor Vehicles for a fleet of six driverless vehicles, facilitating the total operational coverage over 100 square kilometers. Countless stealth technology iterations and numerous driverless readiness evaluations executed by a top-notch team have reinforced this significant milestone. As U.S. cities reopen in phases